Alps Medical Breakthroughs ETF (SBIO)
$40.08
1.04 (2.53%)
SBIO Stock Quote Delayed 15 Minutes
Previous Close
$40.08
Market Cap
182.36M
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
69,100
Day's Range
39.72 - 41.37
52-Week Range
30.14 - 43.96
Dividend & Yield
0.58 (1.44%)
SBIO Stock Predictions, Articles, and Alps Medical Breakthroughs ETF News
7 Biotech ETFs That Should Remain Healthy
The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.
Best ETFs for 2018: Don’t Sweat This Quarter for the SBIO ETF
On a year-to-date basis, SBIO still looks good, up 14.30%, or 310 basis points better than the Nasdaq Biotechnology Index. Year-to-date, SBIO is also outpacing the equal-weight S&P Biotechnology Select Industry Index.
Best ETFs For 2018: A Solid Start for the ALPS Medical Breakthroughs ETF
My pick for the Best ETFs contest, SBIO, is outpacing the Nasdaq Biotechnology Index by 600 basis points with the first quarter drawing to a close.
Best ETFs for 2018: Break Through With the ALPS Medical Breakthroughs ETF
Trying to pick just the right biotech stock to invest in? The ALPS Medical Breakthroughs ETF (SBIO) eases that burden.
4 Frightful ETFs of This Year (VXX, TAPR, KWT, BBC)
Let's take a look Inside four heavily losing ETFs in the year-to-date frame.
Bet on a Bounce with These Biotech ETFs
Biotech stocks may have taken a beating lately, but that may just make these biotech ETFs more of a bargain.
